4basebio UK Societas 2020 Final Results - Annual Report

4basebio UK Societas is a specialist life sciences company focused on supplying therapeutic DNA for gene therapies and gene-based vaccines, along with non-viral nanoparticle delivery solutions. The company was spun out of German-listed 4basebio AG in December 2020 and admitted to AIM in February 2021. Its 2020 results highlight expansion into new laboratory facilities near Cambridge and development of DNA scaling capabilities, positioning the group for commercialization in 2021-2022.